Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19

Timothy J. Poterucha(Mayo Clinic), Elaine Y. Wan(NewYork–Presbyterian Hospital), J. Fried(Columbia University Irving Medical Center), Frederick Ehlert(Columbia University Irving Medical Center), Nir Uriel(Columbia University), John Morrow(Columbia University), Hannah Rosenblum(Columbia University Irving Medical Center), José Dizon(Columbia University Irving Medical Center), Kevin J. Clerkin(Columbia University Irving Medical Center), Adler Perotte(Columbia University), Hasan Garan(Massachusetts General Hospital), Björn Redfors(Cardiovascular Research Foundation), Jan M. Griffin(Columbia University Irving Medical Center), Angelo Biviano(Columbia University), Sneha S. Jain(Palo Alto University), Daniel Burkhoff(Witten/Herdecke University), Allan Schwartz(NewYork–Presbyterian Hospital), J. Raikhelkar(Columbia University Irving Medical Center), Pierre Elias(Columbia University Irving Medical Center), Ersilia M. DeFilippis(Cornell University), Mathew S. Maurer(Boston University), Gabriel Sayer(Columbia University Irving Medical Center), Aakriti Gupta, Mahesh V. Madhavan(NewYork–Presbyterian Hospital), Deepak Saluja(Columbia University), Hirad Yarmohammadi(Columbia University Irving Medical Center), Andrea Kim(Columbia University Irving Medical Center), Matthew Lawlor(NewYork–Presbyterian Hospital), Martin B. Leon(NewYork–Presbyterian Hospital), LeRoy E. Rabbani(NewYork–Presbyterian Hospital)
Journal of the American Heart Association
November 10, 2020
Cited by 51


Related Papers